Clinical Trials

“Cancer patients treated on clinical trials lived substantially longer than those not treated on trial.” -Journal of ClinicalOncology, 2018 using 12 million patient registry data from National Cancer Database


0 +

Active Studies

0 +

Active Studies
Cancer Types


Cancer Types

Why join a clinical trial?

Clinical trials help advance research and treatment options for cancer patients. If you have an advanced cancer, a rare cancer, or a cancer that has not responded to standard treatment options, exploring a clinical trial may be your best option.

New clinical trials added on Feb 03, 2023

  • A Phase Ib Study to Evaluate the Safety and Preliminary Efficacy of IL6-receptor Antibody Sarilumab in Combination With antiPD1 Antibody Cemiplimab for Patients With Non-small Cell Lung Cancer.

    NCT Number : NCT05704634

  • Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients

    NCT Number : NCT05703295

  • Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced and Incurable Solid Tumors

    NCT Number : NCT05705492

  • Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer

    NCT Number : NCT05705401

  • Liquid Biopsies in Esophageal Cancer

    NCT Number : NCT05704530

  • The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer

    NCT Number : NCT05704231

  • A Combined Exercise Training Program for Women Living With Breast Cancer

    NCT Number : NCT05704855

  • Study of Navtemadlin Plus Pembrolizumab as Maintenance Therapy in Locally Advanced and Metastatic Non-Small Cell Lung Cancer

    NCT Number : NCT05705466

  • Integrating Artificial Intelligence Into Lung Cancer Screening.

    NCT Number : NCT05704920

  • Study of Narazaciclib (ON 123300) Plus Letrozole in Recurrent Metastatic Low-grade Endometrioid Endometrial Cancer

    NCT Number : NCT05705505

  • Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients (Acclaim-3)

    NCT Number : NCT05703971

  • Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance

    NCT Number : NCT05704621

  • NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer

    NCT Number : NCT05704829

  • Development of 3DMPUS as a Decision Support Tool for Patients With Liver Tumors Undergoing Therapy

    NCT Number : NCT05705219

  • EpCAM and p53 Expressions in Infiltrating Duct Carcinoma of the Breast

    NCT Number : NCT05703815

  • PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients

    NCT Number : NCT05704166

  • Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy

    NCT Number : NCT05703269

  • Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases

    NCT Number : NCT05704647

  • Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma

    NCT Number : NCT05703854

  • 3D Ultrasound for the Imaging of Axillary Lymph Nodes in Patients With Breast Cancer

    NCT Number : NCT05704283

  • Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

    NCT Number : NCT05704985

  • Quantitative MRI Assessment of Breast Cancer Therapy Response

    NCT Number : NCT05704062

  • INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701

    NCT Number : NCT05703555

  • FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction

    NCT Number : NCT05703997

  • Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study

    NCT Number : NCT05703399

  • Feasibility and Acceptability of Brief, Telehealth Cognitive Compensatory Training for Pediatric Cancer Patients

    NCT Number : NCT05704790

  • Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy

    NCT Number : NCT05704842

  • Develop and Test the Effects of the 'Computer-Assisted OPD COPSCCP on Early Stage Lung Cancer Patients

    NCT Number : NCT04506359

  • Application of "Heidelberg Triangle" Dissection in Pancreatoduodenectomy and Distal Pancreatectomy

    NCT Number : NCT05703581

  • BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome

    NCT Number : NCT05703542

  • Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

    NCT Number : NCT05704894

  • Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC)

    NCT Number : NCT05704244

  • Digestive Biobank for Exploring Microbiota-host Interactions

    NCT Number : NCT05704413

  • Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases

    NCT Number : NCT05704933

  • Assessment of Clonal Hematopoiesis and Its Relationship to Cardiovascular Disease in Hodgkin Lymphoma Survivors

    NCT Number : NCT05705531

  • A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea

    NCT Number : NCT05703516

  • CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)

    NCT Number : NCT05704192

  • Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)

    NCT Number : NCT05703750

  • Effect of Exercise on Disease Activity in Patients With Ankylosing Spondylitis by SIRI and SII

    NCT Number : NCT05703932

  • The Effect of Metabolic Syndrome on Antiviral Response in People With Chronic Hepatitis B

    NCT Number : NCT05705141

  • Plitidepsin Versus Control in Immunocompromised Adult Participants With Symptomatic COVID-19 Requiring Hospital Care

    NCT Number : NCT05705167

  • A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

    NCT Number : NCT05704049

  • Exercise Incentives for YMCA Based Exercise

    NCT Number : NCT05704712

  • Videocapsule Endoscopy in Lynch Syndrome

    NCT Number : NCT05704010

  • Reiki and Qi-gong Therapy to Improve Negative Emotional States of Anxiety, Depression, and Stress in Type-2 Diabetics

    NCT Number : NCT05704465

  • A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous RO7121932 in Participants With Multiple Sclerosis

    NCT Number : NCT05704361

  • Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy

    NCT Number : NCT03345134

  • Intelligent Moxibustion Robot in the Treatment of Low Back Pain

    NCT Number : NCT05704127

  • A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis

    NCT Number : NCT03398135

  • A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

    NCT Number : NCT05269004

  • Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life

    NCT Number : NCT05706740

  • Assessing the Time Demands of Cancer

    NCT Number : NCT05708703

  • Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer

    NCT Number : NCT05705921

  • 18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: A Pilot Study

    NCT Number : NCT05707182

  • Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials

    NCT Number : NCT05706974

  • MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

    NCT Number : NCT05708924

  • A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer

    NCT Number : NCT05708599

  • Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Rectum Cancer

    NCT Number : NCT05706779

  • Short-term Outcomes of Laparoscopic Versus Open Gastrectomy With Lymph Node Dissection for Early Gastric Cancer :a Randomized Controlled Study

    NCT Number : NCT05707338

  • Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors

    NCT Number : NCT05705687

  • A Pilot Feasibility Trial of a Tailored Intervention to Improve Adherence in Adolescents and Young Adults With Cancer

    NCT Number : NCT05706610

  • Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)

    NCT Number : NCT05705700

  • Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer

    NCT Number : NCT05707468

  • A Case Crossover Study of Intermittent Fasting in CLL/SLL

    NCT Number : NCT05708326

  • A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors

    NCT Number : NCT05708950

  • Pilot Study to Evaluate Utility of EnteroTracker® as a Minimally Invasive Sampling Method to Screen for Barrett's Esophagus and Esophageal Cancer

    NCT Number : NCT05706025

  • A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population

    NCT Number : NCT05708235

  • A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

    NCT Number : NCT05706129

  • A Phase I Clinical Trial Using Genetically Engineered Autologous T Cells to Express Chimeric Antigen Receptor (CAR) for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies

    NCT Number : NCT05705570

  • Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

    NCT Number : NCT05706766

  • Smoking, Stress, HIV and Mobile Technology

    NCT Number : NCT05709002

  • Retrospective Review of Esophageal Cancer at MSKCC

    NCT Number : NCT05706558

  • Clinical and Molecular Findings in Patients With Cervical/Supraclavicular Metastasis From Non-small-cell Lung Cancer (NSCLC)

    NCT Number : NCT05706883

  • Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies

    NCT Number : NCT05707325

  • Diet and Cognitive Training in Hematologic Cancer Survivors

    NCT Number : NCT05708716

  • Staging Endometrial caNcer Based on molEcular ClAssification

    NCT Number : NCT05707312

  • PET/CT Follow up for Head and Neck Squamous Cell Carcinoma

    NCT Number : NCT05707078

  • NIR Fluorescent Molecular Probe for the Identification of Breast Tissue

    NCT Number : NCT05708144

  • CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First Remission

    NCT Number : NCT05707273

  • A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors(MEETCD8-001)

    NCT Number : NCT05707676

  • The Effect of Methods of Self-regulation of Mental State on Pain Perception in the Postoperative Period in Colon Cancer Patients

    NCT Number : NCT05708872

  • A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer

    NCT Number : NCT05712174

  • An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer

    NCT Number : NCT05712473

  • Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)

    NCT Number : NCT05710666

  • Radiomics-based Malnutrition for Cervical Cancer.

    NCT Number : NCT05709769

  • Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

    NCT Number : NCT05710328

  • Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

    NCT Number : NCT05710406

  • MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

    NCT Number : NCT05710380

  • A Prospective, Single-arm, Multicenter Clinical Trial of Safety and Effectiveness of EUS-LA for Liver Cancer

    NCT Number : NCT05709886

  • A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

    NCT Number : NCT05710848

  • A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)

    NCT Number : NCT05709158

  • Cost-utility of Focal HIFU vs Prostatectomy

    NCT Number : NCT05710861

  • Rare Embryonal Tumors of the Central Nervous System: International Registry

    NCT Number : NCT05711992

  • Comparison of Ultrasound-guided Erector Spinae Plane Block and Transmuscular Quadratus Lumborum Block

    NCT Number : NCT05709899

  • PSMA-PET/CT Registry

    NCT Number : NCT05709535

  • Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer

    NCT Number : NCT05709574

  • Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer

    NCT Number : NCT05710679

  • The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer

    NCT Number : NCT05710809

  • Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

    NCT Number : NCT05711615

  • Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant

    NCT Number : NCT05709912

  • Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC

    NCT Number : NCT05709782

  • A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors

    NCT Number : NCT05712356

  • Dose De-escalation in Prostate Radiotherapy Using the MRL

    NCT Number : NCT05709496

  • A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

    NCT Number : NCT05711667

  • A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.

    NCT Number : NCT03469011

  • Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients

    NCT Number : NCT05709522

  • The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App for Bladder Cancer Patients

    NCT Number : NCT05710159

  • IMM60 and Pembrolizumab in Melanoma and NSCLC

    NCT Number : NCT05709821

  • Busulfan Sample Collection Study

    NCT Number : NCT05711732

  • A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma

    NCT Number : NCT05711628

  • Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer

    NCT Number : NCT02226276

  • Lung Cancer Diagnosis by Detecting Epigenetic Imprinting Alterations in Bronchoalveolar Lavage

    NCT Number : NCT05707585

  • Xian-Lian-Jie-Du Optimization Decoction as an Adjuvant Treatment for Prevention of Recurrence of Colon Cancer

    NCT Number : NCT05709249

  • Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery

    NCT Number : NCT05711030

  • Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors

    NCT Number : NCT05707910

  • Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy

    NCT Number : NCT05707286

  • A Prospective Study of Surgical Treatment Strategies for Chordoma

    NCT Number : NCT05707767

  • A Study of HB0030 Injection in Patients With Advanced Solid Tumors

    NCT Number : NCT05706207

  • Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors

    NCT Number : NCT05712668

  • A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma

    NCT Number : NCT05705583

  • The Effectiveness of Adding Braun Anastomosis to Standard Child Reconstruction After Pancreatoduodenectomy

    NCT Number : NCT05709197

  • Follow-up of Cell Changes in the Cervix

    NCT Number : NCT05709730

  • Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia

    NCT Number : NCT05707702

  • A Phase 2 Study of the Ketogenic Diet vs Standard Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

    NCT Number : NCT05708352

  • Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma

    NCT Number : NCT05707819

  • Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

    NCT Number : NCT05712694

  • A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

    NCT Number : NCT05705635

  • The Food-effect on Alectinib Pharmacokinetics

    NCT Number : NCT05710133

  • A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia

    NCT Number : NCT05712278

  • Nitrate INFORMER Water Study

    NCT Number : NCT05710341

  • Bicyclol in the Treatment of Antineoplastic Drug-induced Liver Injury.

    NCT Number : NCT05711459

  • Potential Drug Interaction Between ALXN2040 and Rosuvastatin

    NCT Number : NCT05708573

  • Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC

    NCT Number : NCT05711823

  • Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children

    NCT Number : NCT05708391

  • PROs Following Low-dose Irradiation for Osteoarthritis

    NCT Number : NCT05705947

  • Evaluation of Role of Intraoperative Ultrasound in Gross Total Resection of Gliomas

    NCT Number : NCT05707728

  • Prospective Observational Study on the Incidence of Opportunistic Fungal Infections

    NCT Number : NCT05707156

  • A Study of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple Myeloma

    NCT Number : NCT05712083

  • Biomarker Study in Patients With Trigeminal Neuralgia

    NCT Number : NCT05685797

  • Written Recommendation to Improve Adherence in Poor Bowel Preparation

    NCT Number : NCT05709145

  • Long-term Benefit of MPA in Liver Transplantation

    NCT Number : NCT05707520

  • Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma

    NCT Number : NCT05705791

  • AI Assisted the Diagnosis of Pancreatic Solid Lesions

    NCT Number : NCT05706415

  • Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

    NCT Number : NCT04229979

  • The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study

    NCT Number : NCT05712603

  • Impact of SE of the Proximal Colon on the MAR

    NCT Number : NCT05712304

  • Rural Engagement in TelemedTeam for Options in Obesity Treatment Solutions

    NCT Number : NCT05710510

  • A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)

    NCT Number : NCT05709093

  • Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction

    NCT Number : NCT05711719

  • Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge

    NCT Number : NCT02639299

  • Lyophilized Fecal Microbiome Transfer Versus Vancomycin Monotherapy for Primary Clostridioides Difficile Infection in Adults (DONATE)

    NCT Number : NCT05709184

  • Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients

    NCT Number : NCT05705973

  • A Randomized Trial of a Sphenopalatine Ganglion Block With Bupivacaine for Acute Headache

    NCT Number : NCT05707754

  • Gut- and Vaginal Microbiome Composition in Association With PCOS

    NCT Number : NCT05706922

  • Phase II/III Immunogenicity and Safety Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.

    NCT Number : NCT05710783

Want alerts of new clinical trials into your email inbox? Subscribe today

Find a Trial

Enter a few details below to get started and we'll help you match up with active clinical trials

Cancer Details

8424 Trials found

Cancer Details

Eligibility Criteria


OncoPower Clinical Trial Features

OncoPower Clinical Trial Features


Clinical Trial Matching

Fill out your profile and we’ll match you with clinical trial opportunities that are tailored to you


Eligiblity Verification

We work directly with the researchers on your behalf to cut through the pile of paperwork and streamline inclusion and exclusion criteria


Reimbursement Options

Our team will connect you with financial resources available to clinical trial participants


Trial Sponsor Coordination

OncoPower works with the sponsoring organization to make sure you don’t have to do things twice when being onboarded with a clinical trial

FAQs For Patients

Clinical trials for cancer often compare a new drug or treatment modality with the current standard of care. Depending on the trial, you may be able to stay on your current medication. In addition to that, some Clinical trials in cancer are observational and follow a large population over several years and try to understand how other factors impact disease progression and survivorship. These often allow you to continue your course of treatment with your current team and answer survey questions from the research team.

There are some clinical trials that provide compensation and/or reimbursement for expenses. One advantage of using OncoPower to identify and connect with the right clinical trial is that we do some of this legwork for you. Our team will help identify and connect you with financial benefits open to you (some through the study sponsor, some through outside non-profits).

Time spent will vary greatly depending on the clinical trial and treatment being studied. OncoPower will help you understand this as you will find this information out during the informed consent process.

You are able to leave a clinical trial at any time, for any reason.

Every clinical trial has unique and specific inclusion and exclusion criteria that help the researchers. If you don’t qualify for a trial you’re interested in but would like to learn about more trials, simply fill out your patient profile on OncoPower and indicate that you’re interested in Clinical Trials and we’ll help match you to suitable trials.

Create Your Free Account Today

Begin offering a comprehensive digital experience for your patients.